Evidence map›Paper›PMID 42583469›Full record

ReviewCureus2026

Metric Anatomy of Pain: A Critical Analysis of Assessment Tools in Algological Practice.

Juan J Valero Quintero, Héctor Aceituno, Luisana Maldonado-De Santiago, Jennifer Vela-Poveda, José Vásconez-Fabre

Abstract readReview
In one paragraph

Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Juan J Valero QuinteroNeurosurgery, Central University of Venezuela, Caracas, VEN.
Héctor AceitunoNeurosurgery, Hospital San Juan de Dios de Curicó, Curicó, CHL.
Luisana Maldonado-De SantiagoGeneral Medicine, Servicio de Alta Resolutividad (SAR) Bombero Garrido, Curicó, CHL.
Jennifer Vela-PovedaGeneral Medicine, Centro de Salud Familiar (CESFAM) Oriente, San Fernando, CHL.
José Vásconez-FabreNeurosurgery, Clínica Miguel Claro, Santiago, CHL.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pain assessment conditions the quality of the therapeutic process in a context reshaped by the 2020 International Association for the Study of Pain (IASP) definitional update, the 2017 introduction of the nociplastic mechanistic descriptor, and the recognition of chronic primary pain as an autonomous nosological entity in the International Classification of Diseases, 11th Revision (ICD-11). In this scenario, we conducted a structured narrative review of hybrid architecture, conceived as an instrument mapping review with the deliberate incorporation of elements proper to systematic reviews of measurement instruments, following the Scale for the Assessment of Narrative Review Articles (SANRA) and the principles of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR). A systematized search was performed across seven databases (PubMed/MEDLINE, Cochrane Library, Embase, Scopus, PsycINFO, CINAHL, and BVS-LILACS) from January 2000 to February 2026, complemented by hand-searching the guidelines of the main international algological societies (IASP, Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials {IMMPACT}, American Geriatrics Society {AGS}, European Pain Federation (EFIC), Society of Critical Care Medicine {SCCM}/Pain, Agitation/Sedation, Delirium, Immobility, Sleep {PADIS}, Institute for Clinical Systems Improvement {ICSI}). The research question was structured according to the COnsensus-based Standards for the selection of health Measurement INstruments guidelines for patient-reported outcome measure (COSMIN-PROM) framework, and the 79 included studies were critically appraised using a principal evaluative core (COSMIN Risk of Bias, A MeaSurement Tool to Assess systematic Reviews, version 2 {AMSTAR-2}, and Quality Assessment of Diagnostic Accuracy Studies, version 2 {QUADAS-2}), complemented by RoB 2, ROBINS-I, and AGREE II for the corresponding subsets, with additional calculation of derived diagnostic indices (positive and negative likelihood ratios, diagnostic odds ratio, and Youden index) for screening scales. Instruments were organized in a four-axis operational taxonomy comprising unidimensional intensity scales, multidimensional scales, neuropathic pain-specific scales, pediatric scales, observational scales for non-communicative critically ill patients, observational scales for cognitive impairment and dementia, functional and quality-of-life scales, and psychological scales. The majority of the psychometric studies included (63% per COSMIN Risk of Bias) exhibited low risk of bias, while the principal psychometric deficits concentrated in the limited discriminant validity of neuropathic screening scales vs. nociplastic pain, the insufficient responsiveness evidence in observational geriatric scales, and the heterogeneity of Spanish and Portuguese cross-cultural adaptations. No universal scale exists; optimal selection depends on clinical context, age, cognitive status, mechanistic descriptor, and evaluation objectives. The multimodal integration of unidimensional instruments with functional, cognitive, and behavioral scales operationalizes the biopsychosocial approach that constitutes the contemporary standard for comprehensive chronic pain assessment. The COSMIN-compliant adaptation and revalidation of key instruments in Ibero-American populations constitutes a translational research priority.

Indexed as

behavioral pain scalesbiopsychosocial modelchronic paincosmincross-cultural adaptationnociplastic painpain assessmentpain measurementpatient-reported outcome measurespsychometrics

Identifiers

PMID42583469
PMCPMC13460416

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.